ITIH4 and malignant colon neoplasm: Downregulation of ITIH4 in cancer tissue was detectable in tumors of the kidney (95%), stomach (63%) and ovary (57%) as well as in colon cancer (54%), lung cancer (52%), rectum cancer (50%), and prostate cancer (75%).